Tumor Burden Affects Efficacy of Combination Immunotherapy.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2019-021
Abstract: Combined CTLA4 and PD-L1 blockade hinders antitumor immunity in patients with low tumor burden. read more here.
Keywords: efficacy combination; tumor burden; tumor; burden affects ... See more keywords